Skip to main content
SpringerLink
Log in
Book cover

Postmenopausal Diseases and Disorders pp 295–303Cite as

Vasomotor Symptoms: Clinical Management

  • Chapter
  • First Online:

  • 640 Accesses

Abstract

Vasomotor symptoms (VMS) or “hot flashes” are the most common complaint during the menopausal transition. Despite they affect quality of life and appear to be linked to cardiovascular, bone, and brain health, only a minor seek medical attention for treatment.

The management of VMS is based on the symptom’s intensity and frequency and the women’s medical history and personal choice. There are several options for the treatment of hot flashes related to menopause, being the most effective the hormonal therapy. These data is supported by placebo-controlled trials.

For those postmenopausal women with medical contraindications to estrogen or personal preference not to use hormonal therapies, there are options with good results, including paroxetine, venlafaxine, desvenlafaxine, citalopram, escitalopram, and gabapentin.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Thurston RC, Joffe H. Vasomotor symptoms and menopause: findings from the Study of Women’s Health across the Nation. Obstet Gynecol Clin N Am. 2011;38(3):489–501.

    Article  Google Scholar 

  2. Blümel JE, Chedraui P, Baron G, Belzares E, Bencosme A, Calle A, et al. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women. Menopause. 2011;18(7):778–85.

    Article  Google Scholar 

  3. Freedman RR. Menopausal hot flashes: mechanisms, endocrinology, treatment. J Steroid Biochem Mol Biol. 2014;142:115–20.

    Article  CAS  Google Scholar 

  4. The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017;24(7):728–53.

    Article  Google Scholar 

  5. Kravitz HM, Joffe H. Sleep during the perimenopause: a SWAN story. Obstet Gynecol Clin N Am. 2011;38(3):567–86.

    Article  Google Scholar 

  6. Avis NE, Crawford SL, Greendale G, Bromberger JT, Everson-Rose SA, Gold EB, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015;175(4):531–9.

    Article  Google Scholar 

  7. ACOG Practice Bulletin No. 141: management of menopausal symptoms. Obstet Gynecol. 2014;123(1):202–16.

    Google Scholar 

  8. Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause. 2015;22(11):1155–72; quiz 73–4.

    Google Scholar 

  9. Hickey M, Szabo RA, Hunter MS. Non-hormonal treatments for menopausal symptoms. BMJ. 2017;359:j5101.

    Article  Google Scholar 

  10. Daley A, Stokes-Lampard H, Thomas A, MacArthur C. Exercise for vasomotor menopausal symptoms. Cochrane Database Syst Rev. 2014;(11):CD006108.

    Google Scholar 

  11. Cramer H, Peng W, Lauche R. Yoga for menopausal symptoms-a systematic review and meta-analysis. Maturitas. 2018;109:13–25.

    Article  Google Scholar 

  12. Mann E, Smith MJ, Hellier J, Balabanovic JA, Hamed H, Grunfeld EA, et al. Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial. Lancet Oncol. 2012;13(3):309–18.

    Article  Google Scholar 

  13. Ayers B, Smith M, Hellier J, Mann E, Hunter MS. Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial. Menopause. 2012;19(7):749–59.

    Article  Google Scholar 

  14. Goldstein KM, Shepherd-Banigan M, Coeytaux RR, McDuffie JR, Adam S, Befus D, et al. Use of mindfulness, meditation and relaxation to treat vasomotor symptoms. Climacteric. 2017;20(2):178–82.

    Article  CAS  Google Scholar 

  15. Saensak S, Vutyavanich T, Somboonporn W, Srisurapanont M. Relaxation for perimenopausal and postmenopausal symptoms. Cochrane Database Syst Rev. 2014;(7):CD008582.

    Google Scholar 

  16. Elkins GR, Fisher WI, Johnson AK, Carpenter JS, Keith TZ. Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial. Menopause. 2013;20(3):291–8.

    PubMed  Google Scholar 

  17. Barton DL, Loprinzi CL, Quella SK, Sloan JA, Veeder MH, Egner JR, et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol. 1998;16(2):495–500.

    Article  CAS  Google Scholar 

  18. Bianchi MS, Ferreira CF, Fregni F, Schestatsky P, Caumo W, Wender MCO. Transcranial direct current stimulation effects on menopausal vasomotor symptoms. Menopause. 2017;24(10):1122–8.

    Article  Google Scholar 

  19. Lee MS, Shin BC, Ernst E. Acupuncture for treating menopausal hot flushes: a systematic review. Climacteric. 2009;12(1):16–25.

    Article  CAS  Google Scholar 

  20. Dodin S, Blanchet C, Marc I, Ernst E, Wu T, Vaillancourt C, et al. Acupuncture for menopausal hot flushes. Cochrane Database Syst Rev. 2013;(7):CD007410.

    Google Scholar 

  21. Ee C, French SD, Xue CC, Pirotta M, Teede H. Acupuncture for menopausal hot flashes: clinical evidence update and its relevance to decision making. Menopause. 2017;24(8):980–7.

    Article  Google Scholar 

  22. Taylor-Swanson L, Thomas A, Ismail R, Schnall JG, Cray L, Mitchell ES, et al. Effects of traditional Chinese medicine on symptom clusters during the menopausal transition. Climacteric. 2015;18(2):142–56.

    Article  CAS  Google Scholar 

  23. Befus D, Coeytaux RR, Goldstein KM, McDuffie JR, Shepherd-Banigan M, Goode AP, et al. Management of menopause symptoms with acupuncture: an umbrella systematic review and meta-analysis. J Altern Complement Med. 2018;24(4):314–23.

    Article  Google Scholar 

  24. Cobin RH, Goodman NF, Committee ARES. American association of clinical endocrinologists and American college of endocrinology position statement on menopause-2017 update. Endocr Pract. 2017;23(7):869–80.

    Article  Google Scholar 

  25. Lethaby A, Marjoribanks J, Kronenberg F, Roberts H, Eden J, Brown J. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst Rev. 2013;(12):CD001395.

    Google Scholar 

  26. Chen MN, Lin CC, Liu CF. Efficacy of phytoestrogens for menopausal symptoms: a meta-analysis and systematic review. Climacteric. 2015;18(2):260–9.

    Article  CAS  Google Scholar 

  27. Society NAM. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010). Menopause. 2011;18(7):732–53.

    Article  Google Scholar 

  28. Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database Syst Rev. 2012;(9):CD007244.

    Google Scholar 

  29. Baber RJ, Panay N, Fenton A, Group IW. 2016 IMS recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016;19(2):109–50.

    Article  CAS  Google Scholar 

  30. Maclennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev. 2004;(4):CD002978.

    Google Scholar 

  31. Komm BS, Mirkin S. Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy. Int J Women’s Health. 2012;4:129–40.

    Article  CAS  Google Scholar 

  32. Lobo RA, Pinkerton JV, Gass ML, Dorin MH, Ronkin S, Pickar JH, et al. Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile. Fertil Steril. 2009;92(3):1025–38.

    Article  CAS  Google Scholar 

  33. Cummings SR, Ettinger B, Delmas PD, Kenemans P, Stathopoulos V, Verweij P, et al. The effects of tibolone in older postmenopausal women. N Engl J Med. 2008;359(7):697–708.

    Article  CAS  Google Scholar 

  34. Serati M, Uccella S, Bolis P. Tibolone in older postmenopausal women. N Engl J Med. 2008;359(20):2173. author reply.

    CAS  PubMed  Google Scholar 

  35. Nelson HD, Vesco KK, Haney E, Fu R, Nedrow A, Miller J, et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA. 2006;295(17):2057–71.

    Article  CAS  Google Scholar 

  36. Rada G, Capurro D, Pantoja T, Corbalán J, Moreno G, Letelier LM, et al. Non-hormonal interventions for hot flushes in women with a history of breast cancer. Cochrane Database Syst Rev. 2010;(9):CD004923.

    Google Scholar 

  37. Stearns V, Beebe KL, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA. 2003;289(21):2827–34.

    Article  CAS  Google Scholar 

  38. Stearns V, Slack R, Greep N, Henry-Tilman R, Osborne M, Bunnell C, et al. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol. 2005;23(28):6919–30.

    Article  CAS  Google Scholar 

  39. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, LaVasseur BI, Barton DL, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet. 2000;356(9247):2059–63.

    Article  CAS  Google Scholar 

  40. Evans ML, Pritts E, Vittinghoff E, McClish K, Morgan KS, Jaffe RB. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial. Obstet Gynecol. 2005;105(1):161–6.

    Article  CAS  Google Scholar 

  41. Carpenter JS, Storniolo AM, Johns S, Monahan PO, Azzouz F, Elam JL, et al. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer. Oncologist. 2007;12(1):124–35.

    Article  CAS  Google Scholar 

  42. Archer DF, Seidman L, Constantine GD, Pickar JH, Olivier S. A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause. Am J Obstet Gynecol. 2009;200(2):172.e1–10.

    Article  Google Scholar 

  43. Bouchard P, Panay N, de Villiers TJ, Vincendon P, Bao W, Cheng RJ, et al. Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms. Climacteric. 2012;15(1):12–20.

    Article  CAS  Google Scholar 

  44. Pinkerton JV, Constantine G, Hwang E, Cheng RF, Investigators S. Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial. Menopause. 2013;20(1):28–37.

    Article  Google Scholar 

  45. Pinkerton JV, Archer DF, Guico-Pabia CJ, Hwang E, Cheng RF. Maintenance of the efficacy of desvenlafaxine in menopausal vasomotor symptoms: a 1-year randomized controlled trial. Menopause. 2013;20(1):38–46.

    Article  Google Scholar 

  46. Barton DL, LaVasseur BI, Sloan JA, Stawis AN, Flynn KA, Dyar M, et al. Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9. J Clin Oncol. 2010;28(20):3278–83.

    Article  CAS  Google Scholar 

  47. Freeman EW, Guthrie KA, Caan B, Sternfeld B, Cohen LS, Joffe H, et al. Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. JAMA. 2011;305(3):267–74.

    Article  CAS  Google Scholar 

  48. Freedman RR, Kruger ML, Tancer ME. Escitalopram treatment of menopausal hot flashes. Menopause. 2011;18(8):893–6.

    Article  Google Scholar 

  49. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol. 2002;20(6):1578–83.

    Article  CAS  Google Scholar 

  50. Suvanto-Luukkonen E, Koivunen R, Sundström H, Bloigu R, Karjalainen E, Häivä-Mällinen L, et al. Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study. Menopause. 2005;12(1):18–26.

    Article  Google Scholar 

  51. Kimmick GG, Lovato J, McQuellon R, Robinson E, Muss HB. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen. Breast J. 2006;12(2):114–22.

    Article  Google Scholar 

  52. Gordon PR, Kerwin JP, Boesen KG, Senf J. Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population. Menopause. 2006;13(4):568–75.

    Article  Google Scholar 

  53. Grady D, Cohen B, Tice J, Kristof M, Olyaie A, Sawaya GF. Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trial. Obstet Gynecol. 2007;109(4):823–30.

    Article  CAS  Google Scholar 

  54. Desmarais JE, Looper KJ. Interactions between tamoxifen and antidepressants via cytochrome P450 2D6. J Clin Psychiatry. 2009;70(12):1688–97.

    Article  CAS  Google Scholar 

  55. Brown JN, Wright BR. Use of gabapentin in patients experiencing hot flashes. Pharmacotherapy. 2009;29(1):74–81.

    Article  CAS  Google Scholar 

  56. Pandya KJ, Morrow GR, Roscoe JA, Zhao H, Hickok JT, Pajon E, et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet. 2005;366(9488):818–24.

    Article  CAS  Google Scholar 

  57. Hayes LP, Carroll DG, Kelley KW. Use of gabapentin for the management of natural or surgical menopausal hot flashes. Ann Pharmacother. 2011;45(3):388–94.

    Article  CAS  Google Scholar 

  58. Bordeleau L, Pritchard KI, Loprinzi CL, Ennis M, Jugovic O, Warr D, et al. Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors. J Clin Oncol. 2010;28(35):5147–52.

    Article  CAS  Google Scholar 

  59. Loprinzi CL, Qin R, Balcueva EP, Baclueva EP, Flynn KA, Rowland KM, et al. Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1. J Clin Oncol. 2010;28(4):641–7.

    Article  CAS  Google Scholar 

  60. Borba CM, Ferreira CF, Ferreira FV, Bianchi MS, Dall’Agno ML, Pérez-Lopez FR, et al. Sulpiride attenuates hot flashes: initial results from a randomized, double-blind clinical trial. 2019 (In preparation).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Programa de Pós-Graduação em Ciências da Saúde: Ginecologia e Obstetrícia, Grupo de Pesquisa Climatério e Menopausa, Serviço de Ginecologia e Obstetrícia, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil

    Maria Celeste Osorio-Wender & Mona Lúcia Dall’Agno

Authors
  1. Maria Celeste Osorio-Wender
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mona Lúcia Dall’Agno
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Celeste Osorio-Wender .

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, University of Zaragoza Facultad de Medicina, Zaragoza, Spain

    Faustino R. Pérez-López

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Osorio-Wender, M.C., Dall’Agno, M.L. (2019). Vasomotor Symptoms: Clinical Management. In: Pérez-López, F. (eds) Postmenopausal Diseases and Disorders. Springer, Cham. https://doi.org/10.1007/978-3-030-13936-0_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-13936-0_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-13935-3

  • Online ISBN: 978-3-030-13936-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation